The pharmaceutical industry is in constant pursuit of novel therapeutics, and the synthesis of enantiomerically pure compounds is a critical element in this endeavor. Di-p-anisoyl-D-tartaric Acid (CAS 191605-10-4) has emerged as an indispensable tool for researchers and manufacturers working at the forefront of pharmaceutical innovation. Its unique chiral properties make it exceptionally valuable for both the resolution of racemic mixtures and as a key intermediate in asymmetric synthesis.

At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to supporting pharmaceutical advancements by providing high-quality specialty chemicals. As a leading manufacturer and supplier of Di-p-anisoyl-D-tartaric Acid, we understand its pivotal role in drug development and are committed to ensuring its availability and quality for our B2B clients.

Facilitating Pharmaceutical Development Through Chirality

Chirality is a fundamental concept in medicinal chemistry. The two enantiomers of a chiral drug can exhibit significant differences in their pharmacological activity, metabolism, and toxicity. Therefore, synthesizing and utilizing single enantiomers is often crucial for drug efficacy and patient safety. This is where Di-p-anisoyl-D-tartaric Acid plays a vital role:

  • Chiral Resolution: It acts as a highly effective resolving agent, enabling the separation of racemic drug precursors or intermediates into their constituent enantiomers. This process is essential for producing stereochemically pure active pharmaceutical ingredients (APIs).
  • Asymmetric Synthesis: As a chiral auxiliary or catalyst component, it guides chemical reactions to selectively produce one enantiomer over the other, streamlining the synthesis of chiral APIs and reducing the need for later resolution steps.

When you choose to buy Di-p-anisoyl-D-tartaric acid, you are investing in a compound that directly contributes to the purity and potency of your pharmaceutical products.

Quality and Reliability from a Trusted Supplier

The pharmaceutical industry demands uncompromising quality. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our Di-p-anisoyl-D-tartaric Acid (CAS 191605-10-4) meets the highest standards, with typical assays of ≥99.0%. This high purity is critical for reliable performance in sensitive pharmaceutical synthesis processes.

As a reputable manufacturer and supplier in China, we offer:

  • Consistent Quality: Our rigorous quality control processes guarantee that every batch meets exact specifications.
  • Stable Supply: We provide a dependable supply chain, crucial for uninterrupted pharmaceutical production schedules.
  • Competitive Pricing: We strive to offer cost-effective solutions without compromising on the quality required for pharmaceutical applications.
  • Technical Support: Our team is available to provide information and assistance regarding product applications and specifications.

Partnering for Pharmaceutical Success

For pharmaceutical companies seeking to optimize their synthetic routes and ensure the enantiomeric purity of their APIs, sourcing key chiral intermediates like Di-p-anisoyl-D-tartaric Acid from a trusted partner is essential. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being that partner.

We encourage pharmaceutical innovators to request a quote for Di-p-anisoyl-D-tartaric Acid (CAS 191605-10-4). Let us be your reliable source for this vital chemical, contributing to the successful development and manufacturing of your next generation of pharmaceuticals.